Usoro، نويسنده , , Andrew O. and Bradford، نويسنده , , Natalie and Shah، نويسنده , , Amit J. and Soliman، نويسنده , , Elsayed Z.، نويسنده ,
The prognostic significance of low QRS voltage (LQRSV) in the electrocardiogram (ECG) of individuals free of cardiovascular disease (CVD) is unclear. We evaluated the association between LQRSV and all-cause mortality in 6,440 participants (53% women, mean age 60 years) from the Third National Health and Nutrition Examination Survey, a representative sample of the US population. Participants with history of CVD or major ECG abnormalities were excluded. LQRSV was automatically defined from standard 12-lead ECG as QRS complex amplitudes of <0.5 mV in all frontal leads and/or <1.0 mV in all precordial leads. Mortality data through 2006 were obtained from National Death Index records. LQRSV was detected in 1.4% (n = 89) of the participants. During a median follow-up of 13.8 years, 2,000 deaths occurred. The mortality rate in individuals with LQRSV was almost twice that in those without LQRSV (51.1 vs 23.5 events per 1,000 person-years, p <0.01). In a demographic-adjusted model, LQRSV was associated with 63% increased risk of mortality (hazard ratio 1.63, 95% confidence interval [1.21, 2.18]). The magnitude of this risk did not appreciably change after additional adjustment for body mass index, smoking status, systolic blood pressure, blood pressure medication use, dyslipidemia, diabetes, cancer, pulmonary disease, and ECG abnormalities (hazard ratio 1.61, 95% confidence interval [1.20, 2.16]) and was consistent across age, race, and sex subcategories. In conclusion, LQRSV is associated with an increased risk of mortality in individuals free of apparent CVD. More research is warranted to determine the mechanisms by which LQRSV is associated with increased risk of mortality in apparently healthy individuals.